On July 30, Teradyne rose 3.75% in pre-market trading, trading at $331.392/share, with turnover of $1.2459 million, extending post-earnings momentum.

The company reported Q2 adjusted EPS of $2.47, far exceeding the consensus estimate of $2.09, representing a 333% year-over-year increase from $0.57. Revenue reached $1.33 billion, up 104% year-over-year, surpassing expectations of $1.22 billion. The semiconductor test segment contributed $1.122 billion, driven by robust AI chip testing demand. Net income surged to $374.5 million from $78.4 million a year earlier.

Q3 guidance was equally strong, with revenue projected at $1.2 billion to $1.3 billion, well above the Street estimate of $1.06 billion, and adjusted EPS guidance of $1.85 to $2.15, with the midpoint of $2.00 far exceeding analysts' $1.44 expectation. Cantor Fitzgerald raised its target price from $400 to $550, maintaining an overweight rating. Previously, UBS, JPMorgan, and Goldman Sachs had also lifted targets to the $450-$500 range, reflecting strong institutional confidence in AI-driven growth sustainability.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)